Protalix BioTherapeutics (PLX) Exchange Rate Effect (2010 - 2026)
Protalix BioTherapeutics' (PLX) quarterly Exchange Rate Effect came in at -$77000.0 in Q1 2026, down 862.5% year-on-year from $10098.4 in Q1 2025, and down 148.39% quarter-over-quarter from -$31000.0 in Q4 2025.
Protalix BioTherapeutics (PLX) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics' Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$77000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 862.5% year-over-year to -$77000.0 in Q1 2026; TTM through Mar 2026 was -$116000.0, a 583.33% decrease from a year earlier, with the FY2025 full-year figure at -$47000.0, down 288.0% from the prior year.
- Exchange Rate Effect fell to -$77000.0 in Q1 2026 per PLX's latest filing, from -$31000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $54000.0 in Q4 2024 and bottomed at -$77000.0 in Q1 2026.
- The 5-year median for Exchange Rate Effect is -$16000.0 (2024), against an average of -$18125.0.
- Across the five-year window, Exchange Rate Effect tumbled 900.0% in 2022 and soared 300.0% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at -$26000.0 in 2022, then slipped by 3.85% to -$27000.0 in 2023, then surged by 300.0% to $54000.0 in 2024, then sank by 157.41% to -$31000.0 in 2025, then plunged by 148.39% to -$77000.0 in 2026.
- Per Business Quant, the three latest PLX Exchange Rate Effect figures stand at -$77000.0 (Q1 2026), -$31000.0 (Q4 2025), and -$12000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |